late
decemb
cluster
patient
pneumonia
unknown
etiolog
report
local
health
facil
wuhan
hubei
provinc
china
earli
januari
caus
agent
mysteri
pneumonia
identifi
novel
coronaviru
sever
independ
laboratori
locat
china
caus
viru
temporarili
name
novel
coronaviru
world
health
organ
accord
daili
report
world
health
organ
epidem
far
caus
laboratori
confirm
case
death
china
well
confirm
case
death
countri
februari
coronavirus
distribut
broadli
among
human
anim
caus
respiratori
enter
hepat
neurolog
diseas
far
seventh
member
famili
coronavirus
infect
human
preced
epidem
centuri
alreadi
seen
outbreak
caus
two
highli
pathogen
coronavirus
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
outbreak
result
zoonot
coronaviru
cross
speci
barrier
caus
high
morbid
mortal
human
popul
show
sever
similar
regard
clinic
present
vari
asymptomat
infect
sever
diseas
sever
acut
respiratori
syndrom
therefor
current
knowledg
biolog
patholog
may
provid
clue
ongo
futur
research
effort
concern
investig
review
tri
appli
current
understand
patholog
pathogenesi
character
avail
patholog
data
infect
mainli
obtain
autopsi
predomin
viscer
macroscop
chang
fatal
case
edemat
lung
increas
gross
weight
multipl
area
congest
enlarg
lymph
node
pulmonari
hila
abdomin
caviti
well
diminish
spleen
size
reduc
spleen
weight
morpholog
chang
bronchial
epitheli
denud
loss
cilia
squamou
metaplasia
histolog
featur
earli
phase
pulmonari
infect
commonli
associ
acut
diffus
alveolar
damag
later
phase
diseas
demonstr
combin
diffus
alveolar
damag
acut
fibrin
organ
pneumonia
larg
number
particl
genom
sequenc
detect
within
circul
lymphocyt
monocyt
lymphoid
tissu
well
epitheli
cell
respiratori
tract
intestin
mucosa
epithelium
renal
distal
tubul
neuron
brain
macrophag
resid
differ
organ
rna
cellular
cytokeratin
within
lung
evid
immunofluoresc
situ
hybrid
suggest
pneumocyt
becom
infect
accordingli
electron
microscop
examin
also
show
virion
nucleocapsid
inclus
pneumocyt
addit
may
occasion
identifi
alveolar
macrophag
lung
mechan
underli
sever
pathogen
far
fulli
understood
extens
lung
damag
patient
appear
associ
high
initi
viru
titer
increas
monocyt
macrophag
neutrophil
infiltr
lung
elev
level
serum
proinflammatori
cytokin
chemokin
therefor
clinic
deterior
infect
may
result
combin
direct
cytopath
effect
immunopatholog
induc
studi
chang
cytokinechemokin
profil
infect
reveal
increas
level
circul
cytokin
tumor
necrosi
factor
like
contribut
poor
prognosi
infect
high
serum
level
proinflammatori
cytokin
interferon
transform
growth
chemokin
found
patient
sar
sever
diseas
compar
individu
uncompl
sar
addit
earli
induct
well
subsequ
hyperproduct
coincid
lack
product
thought
contribut
process
involv
lung
injuri
infect
addit
robust
persist
express
gene
isg
accompani
earli
sar
sequela
also
shown
infect
result
delay
express
type
ifn
ifn
signal
accompani
robust
viru
replic
found
promot
accumul
pathogen
inflammatori
monocytemacrophag
result
elev
lung
cytokinechemokin
level
vascular
leakag
impair
cell
respons
understand
pathophysiolog
chang
caus
infect
reli
limit
number
autopsi
biopsi
case
studi
indic
patholog
featur
infect
includ
exud
diffus
alveolar
damag
hyalin
membran
pulmonari
edema
type
ii
pneumocyt
hyperplasia
interstiti
pneumonia
predominantli
lymphocyt
multinucl
syncyti
cell
bronchial
submucos
gland
necrosi
also
observ
bronchial
lesion
compris
patholog
basi
respiratori
failur
radiolog
abnorm
infect
target
cell
infect
lung
includ
pneumocyt
multinucl
epitheli
cell
bronchial
submucos
gland
cell
cell
express
multifunct
cell
surfac
protein
call
dipeptidyl
peptidas
also
known
constitut
primari
entri
receptor
ultrastructur
viral
particl
found
pneumocyt
pulmonari
macrophag
macrophag
infiltr
skelet
muscl
renal
proxim
tubular
epitheli
cell
consist
ultrastructur
find
kidney
renal
biopsi
demonstr
acut
tubulointerstiti
nephriti
acut
tubular
sclerosi
proteinac
cast
format
entri
receptor
wide
express
epitheli
cell
kidney
alveoli
small
intestin
liver
prostat
activ
leukocyt
suggest
rang
tissu
tropism
broader
coronaviru
accordingli
found
abl
infect
mani
human
immun
cell
includ
dendrit
cell
macrophag
cell
infect
dc
macrophag
result
robust
sustain
product
proinflammatori
cytokin
chemokin
proinflammatori
capac
cytokin
thought
caus
least
contribut
immun
cell
infiltr
lower
respiratori
tract
infect
patient
observ
sever
inflamm
well
tissu
damag
infect
cell
result
apoptosi
mediat
combin
extrins
intrins
apoptosi
pathway
mechan
evad
cell
respons
peripher
blood
lymphoid
organ
may
contribut
viru
spread
sever
immunopatholog
moreov
report
also
induc
apoptosi
kidney
lung
cell
upregul
fibroblast
growth
factor
express
approxim
month
onset
outbreak
sever
virolog
clinic
aspect
associ
diseas
still
investig
howev
field
rapidli
move
forward
nevertheless
find
sever
report
await
independ
confirm
regard
precaut
genom
sequenc
earli
outbreak
enabl
rapid
develop
revers
chain
reaction
diagnost
test
specif
genet
sequenc
analysi
reveal
belong
genu
nucleotid
ident
ident
furthermor
report
ident
across
entir
genom
bat
coronaviru
inocul
onto
surfac
layer
human
airway
epitheli
cell
vitro
caus
cytopath
effect
cessat
cilium
beat
cell
infect
cluster
onset
like
affect
older
male
comorbid
result
sever
even
fatal
respiratori
diseas
major
clinic
symptom
result
infect
prodrom
phase
includ
fever
dri
cough
myalgia
fatigu
diarrhea
mani
patient
also
develop
dyspnea
lymphopenia
complic
infect
includ
acut
respiratori
distress
syndrom
rnaaemia
acut
cardiac
injuri
secondari
infect
report
case
includ
asymptomat
patient
abnorm
find
concern
chest
comput
tomographi
ct
indic
bilater
opac
prototyp
find
chest
ct
imag
serious
ill
patient
requir
intens
care
unit
icu
admiss
bilater
multipl
lobular
subsegment
area
consolid
initi
plasma
basic
fgf
gcsf
gmcsf
pdgf
vascular
endotheli
growth
factor
concentr
higher
patient
compar
healthi
control
moreov
icu
patient
show
higher
plasma
level
gscf
patient
result
suggest
immunopatholog
may
also
play
relev
role
develop
diseas
sever
comprehens
lesson
learn
outbreak
provid
despit
inher
tragedi
valuabl
experi
insight
fight
epidem
drug
inhibit
viral
dissemin
disrupt
viral
replic
may
reduc
direct
cytopath
effect
treatment
restrain
host
inflammatori
respons
eg
antibodi
compound
neutral
cytokin
cognat
receptor
ideal
respiratori
tract
may
reduc
infer
combin
treatment
would
suitabl
therapeut
strategi
sever
human
coronaviru
infect
howev
must
bear
mind
current
specif
antivir
treatment
avail
sar
mer
therefor
research
pathogenesi
human
coronaviru
infect
imper
identifi
appropri
therapeut
target
author
declar
conflict
interest
